Synthesis and evaluation of a large library of nitroxoline derivatives as pancreatic cancer antiproliferative agents

References

• Adamska A, Domenichini A, Falasca M. Pancreatic ductal adenocarcinoma: current and evolving therapies. Int J Mol Sci 2017;18:1338.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin 2020;70:7–30.
   PubMed Web of Science ®Google Scholar
• Hajatdoost L, Sedaghat K, Walker EJ, et al. Chemotherapy in pancreatic cancer: a systematic review. Medicina (Kaunas) 2018;54:48.
   Web of Science ®Google Scholar
• Xue H, Li J, Xie H, Wang Y. Review of drug repositioning approaches and resources. Int J Biol Sci 2018;14:1232–44.
   PubMed Web of Science ®Google Scholar
• Veschi S, De Lellis L, Florio R, et al. Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells. J Exp Clin Cancer Res 2018;37:236
   PubMed Web of Science ®Google Scholar
• Veschi S, Ronci M, Lanuti P, et al. Integrative proteomic and functional analyses provide novel insights into the action of the repurposed drug candidate nitroxoline in AsPC-1 cells. Sci Rep 2020;10:2574.
   PubMed Web of Science ®Google Scholar
• Kumari N, Thakur N, Cho HR, Choi SH. Assessment of early therapeutic response to nitroxoline in temozolomide-resistant glioblastoma by amide proton transfer imaging: a preliminary comparative study with diffusion-weighted imaging. Sci Rep 2019;9:5585
   PubMed Web of Science ®Google Scholar
• Lazovic J, Guo L, Nakashima J, et al. Nitroxoline induces apoptosis and slows glioma growth in vivo. Neuro-oncology 2015;17:53–62.
   PubMed Web of Science ®Google Scholar
• Mao H, Du Y, Zhang Z, et al. Nitroxoline shows antimyeloma activity by targeting the TRIM25/p53 axle. Anticancer Drugs 2017;28:376–83.
   PubMed Web of Science ®Google Scholar
• Xu N, Huang L, Li X, et al. The novel combination of nitroxoline and PD-1 blockade, exerts a potent antitumor effect in a mouse model of prostate cancer. Int J Biol Sci 2019;15:919–28.
   PubMed Web of Science ®Google Scholar
• Chen W, Zhang H, Chen Z, et al. Development and evaluation of a novel series of nitroxoline-derived BET inhibitors with antitumor activity in renal cell carcinoma. Oncogenesis 2018;7:83
   PubMed Web of Science ®Google Scholar
• Shim JS, Matsui Y, Bhat S, et al. Effect of nitroxoline on angiogenesis and growth of human bladder cancer. J Natl Cancer Inst 2010;102:1855–73.
   PubMedGoogle Scholar
• Mirković B, Markelc B, Butinar M, et al. Nitroxoline impairs tumor progression in vitro and in vivo by regulating cathepsin B activity. Oncotarget 2015;6:19027–42.
   PubMedGoogle Scholar
• Mitrović A, Kos J. Nitroxoline: repurposing its antimicrobial to antitumor application. Acta Biochim Pol 2019;66:521–31.
   PubMed Web of Science ®Google Scholar
• Torphy RJ, Zhu Y, Schulick RD. Immunotherapy for pancreatic cancer: barriers and breakthroughs. Ann Gastroenterol Surg 2018;2:274–81.
   PubMed Web of Science ®Google Scholar
• Graziano V, Grassadonia A, Iezzi L, et al. Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients. Breast 2019;44:33–8.
   PubMed Web of Science ®Google Scholar
• Mirković B, Renko M, Turk S, et al Novel mechanism of cathepsin B inhibition by antibiotic nitroxoline and related compounds. ChemMedChem 2011;6:1351–6.
   PubMed Web of Science ®Google Scholar
• Sosič I, Mirković B, Arenz K, et al. Development of new Cathepsin B inhibitors: combining bioisosteric replacements and structure-based design to explore the structure-activity relationships of nitroxoline derivatives. J Med Chem 2013;56:521–33.
   PubMed Web of Science ®Google Scholar
• Oliveri V, Vecchio G. 8-Hydroxyquinolines in medicinal chemistry: a structural perspective. Eur J Med Chem 2016;120:252–74.
   PubMed Web of Science ®Google Scholar
• Özdemir Z, Utku S, Mathew B, et al. Synthesis and biological evaluation of new 3(2H)-pyridazinone derivatives as non-toxic anti-proliferative compounds against human colon carcinoma HCT116 cells. J Enzyme Inhib Med Chem 2020;35:1100–9.
   PubMed Web of Science ®Google Scholar
• Lenoci A, Tomassi S, Conte M, et al. Quinoline-based p300 histone acetyltransferase inhibitors with pro-apoptotic activity in human leukemia U937 cells. ChemMedChem 2014;9:542–8.
   PubMed Web of Science ®Google Scholar
• Carradori S, De Monte C, D’Ascenzio M, et al Salen and tetrahydrosalen derivatives act as effective inhibitors of the tumor-associated carbonic anhydrase XII-a new scaffold for designing isoform-selective inhibitors. Bioorg Med Chem Lett 2013;23:6759–63.
   PubMed Web of Science ®Google Scholar
• Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 2017;7:42717.
   PubMed Web of Science ®Google Scholar
• Daina A, Michielin O, Zoete V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Research 2019;47:W357–W364.
   PubMed Web of Science ®Google Scholar
• McMahon RE, Culp HW, Mills J, Marshall FJ. Demethylation studies. IV. The in vitro and in vivo cleavage of alkyl- and arylalkyl-p-nitrophenyl ethers. J Med Chem 1963;6:343–6.
   PubMed Web of Science ®Google Scholar
• Zhu XL, Zhang R, Wu QY, et al. Natural product Neopeltolide as a cytochrome bc1 complex inhibitor: Mechanism of action and structural modification. J. Agric. Food Chem 2019;67:2774–81.
   PubMed Web of Science ®Google Scholar
• Debbabi K, Beji M, Baklouti A. Alkylation des esters sulfamiques par le bromure de 4-fluorobenzyle. Phosphorus Sulfur Silicon Relat Elem 2005;180:1545–51.
   Web of Science ®Google Scholar
• Catalano A, Carocci A, Defrenza I, et al. 2-Aminobenzothiazole derivatives: search for new antifungal agents. Eur J Med Chem 2013;64:357–64.
   PubMed Web of Science ®Google Scholar
• Getz JJ, Prankerd RJ, Sloan KB. Mechanism of hydrolysis of O-imidomethyl derivatives of phenols. J Org Chem 1993;58:4913–8.
   Web of Science ®Google Scholar
• Florio R, De Lellis L, Veschi S, et al. Effects of dichloroacetate as single agent or in combination with GW6471 and metformin in paraganglioma cells. Sci Rep 2018;8:13610.
   PubMed Web of Science ®Google Scholar
• Florio R, Veschi S, di Giacomo V, et al. The benzimidazole-based anthelmintic parbendazole: a repurposed drug candidate that synergizes with gemcitabine in pancreatic cancer. Cancers (Basel) 2019;11:pii:2042.
   Web of Science ®Google Scholar
• Chou TC. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res 2010;70:440–6.
   PubMed Web of Science ®Google Scholar
• Hu S, Jin Y, Liu Y, et al. Synthesis and mechanistic studies of quinolin-chlorobenzothioate derivatives with proteasome inhibitory activity in pancreatic cancer cell lines. Eur J Med Chem 2018;158:884–95.
   PubMed Web of Science ®Google Scholar